Radana Bhaskara Finance Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Radana Bhaskara Finance Tbk. trades at Rp86 (market cap 562.65B, 10.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp250 (market cap 167.37B, 23.1K 24h volume). The key difference: Radana Bhaskara Finance Tbk. is far larger — about 3.4× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (23.1K versus 10.2K). Which is the better fit depends on your goals.
| HDFA | OBAT | |
|---|---|---|
Market Cap | 562.65B | 167.37B |
Volume | 10.2K | 23.1K |
Lot | 102 | 231 |
Turnover | 877.2K | 5.7M |
Average Price | 86 | 246.93 |
Value | 877.2K | 5.7M |
Indicative Equilibrium Price | 100 | 246 |
Indicative Equilibrium Volume | 86.6K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT HD Finance (the company) was incorporated under the name of PT Indonesia Lease Corporation base on notarial deed No.41 of Mr FA Tumbuan, S.H, dated 20 Sep, 1972. The Company's name has been changed from PT HD Finance Tbk to PT Radana Bhaskara Finance Tbk based on the Notarial Deed No. 136 dated May 21, 2014 of Jimmy Tanal, S.H., M.Kn.
Read more on HDFA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →